{
  "docId": "019dd923-622c-750b-8b98-0c85e40ec39b",
  "docSlug": "9b248b07037e",
  "documentTitle": "CareDx, Inc. (CDNA)",
  "authorId": "53_Kerrisdale_Capital",
  "authorName": "Kerrisdale Capital",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2019-07-01 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 14,
  "pageCount": 29,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "villain_critique",
  "function": "expose_gap",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "Kerrisdale Capital research note criticizing CareDx's AlloSure product efficacy.",
  "elementsJson": [
    "bullet_list",
    "paragraph",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b98-0c85e40ec39b/14",
  "deckHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b#slide-14",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "AlloSure is fundamentally incapable of identifying the most common type of kidney rejection",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-203e-77ad-a69d-05286feb916b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.78,
        "x": 0.12,
        "y": 0.09
      },
      "kind": "list",
      "text": "Summarizes findings from Bromberg et al. and Narayanan et al. regarding AlloSure false negative rates in stable kidney patients.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e68b8775-513d-4d12-9932-55e734f1fee2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "detection rate: 40%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd953-203e-77ad-a69d-0ec5626d5225",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.78,
        "x": 0.12,
        "y": 0.35
      },
      "kind": "paragraph",
      "text": "The 3.7% and 5.5% positive rates in the aforementioned studies are indicative of a failure to detect subclinical rejection.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "64956025-1522-441e-ae2c-f761cfcac1c1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.32,
        "w": 0.78,
        "x": 0.12,
        "y": 0.51
      },
      "kind": "paragraph",
      "text": "Discusses Bloom et al. study, highlighting the divergence in accuracy between AMR and TCMR detection, and the structural blind spot hypothesis.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "65ee1c27-faa3-4444-86cb-e94687b7ba5c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "has potential to provide additional information...in the diagnosis, management, and treatment of AMR. — Bloom et al.",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-203e-77ad-a69d-0a8fd2e7303d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.78,
        "x": 0.12,
        "y": 0.86
      },
      "kind": "source-note",
      "text": "Footnotes 18 and 19 regarding false positive rates and referenced studies.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3bc22aa8-27ea-46fd-9348-e8a90c97a3e5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.78,
        "x": 0.12,
        "y": 0.44
      },
      "kind": "title",
      "text": "AlloSure is fundamentally incapable of identifying the most common type of kidney rejection",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c1e14124-3b1f-4c33-abca-ac70bc4faf77",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "076a3de6-b16d-40b4-861f-2732ef292ecb",
      "evidence": "The slide explicitly frames the product's technical limitation as an 'indictment' of the company's business model.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 16,
      "from": 12,
      "beatId": "98a96039-52a0-4f39-824a-abc50d3c23dc",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Villain Critique",
      "beatSlug": null,
      "evidence": "Slides 12-16 critique AlloSure's clinical data and utility",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    },
    {
      "to": 14,
      "from": 13,
      "beatId": "85715bb9-0467-4cac-b70b-dcb33d24e2ba",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Expose Contradiction",
      "beatSlug": null,
      "evidence": "Slides 13-14 expose contradictions in AlloSure's clinical data",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 26,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "6ece1bb9-6dc2-4b36-a983-1e6b3a2a754d",
      "evidence": "The document emphasizes the risks of not acting on AlloSure's ineffectiveness",
      "position": 0,
      "objective": "Highlight the cost of inaction for investors",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}